Safety and Efficacy of Hepatitis B Vaccination in Cirrhosis of Liver by D. Ajith Roni, Rama Mohan Pathapati, A. Sathish Kumar, Lalit Nihal, K. Sridhar, Sujith Tumkur Rajashekar

“…We observed that the alcoholic chronic liver disease had less antibody response (44%) than other causes of chronic liver disease such as cryptogenic 69% and HCV 75%. …”
Get full text

Noninvasive Predictors of High-Risk Varices in Patients with Non-Cirrhotic Portal Hypertension by Morven E. Cunningham, Gilda Parastandeh-Chehr, Orlando Cerocchi, David K. Wong, Keyur Patel

Get full text

Recent advances in polymeric nanoparticles for the treatment of hepatic diseases by Feng Gao, Xuefei Feng, Xinyu Li

“…Compared to traditional therapies, they offer significant advantages in the treatment of liver disease by improving outcomes and reducing side effects. …”
Get full text

Investigation of the healing effects of Afyon Province hot spring waters on experimentally-induced fatty liver in mice by Bülent Elitok, Ibrahim Kişlalioğlu, Yavuz Ulusoy, Bahadır Kilinç

“…Due the increasing number of alcoholic fatty liver disease cases in the world, the development of methods for treating this disease is an urgent task. …”
Get full text

Multi-omics reveals the mechanism of Trimethylamine N-oxide derived from gut microbiota inducing liver fatty of dairy cows by Chenlei Li, Feifei Wang, Yongxia Mao, Yanfen Ma, Yansheng Guo

“…However, the specific role and pathogenesis of TMAO in bovine fatty liver disease remain unclear, limiting our understanding and treatment of the condition. …”
Get full text

Impact of underlying diseases and complications on COVID-19 mortality in South Korea: analysis of national health insurance service data by Kyunghee Lee, Jieun Hwang

“…Except for liver disease, all underlying diseases were associated with mortality. …”
Get full text

Penyeimbangan Kelas SMOTE dan Seleksi Fitur Ensemble Filter pada Support Vector Machine untuk Klasifikasi Penyakit Liver by Muhammad Amir Nugraha, Muhammad Itqan Mazdadi, Andi Farmadi, Muliadi, Triando Hamonangan Saragih

“…Classification of liver disease in patients needs to be done well because the results can help in the initial diagnosis of whether a patient has liver disease. …”
Get full text

Wilson’s Disease and Autoimmune Hepatitis Coexistence: A Cause of Diagnostic Delay by Mohammed G Mudawi, Salma Barakat MD, Elhadi M Awooda

“…Wilson’s disease, although rare, should be suspected in patients with decompensated liver disease. The dominance of clinical and epidemiological features of autoimmune hepatitis as a common causative pathology for chronic liver disease in young and middle-aged ladies may hide the presence of other serious different pathologies such as Wilson’s disease. …”
Get full text

Gambaran Profil Lipid Pasien Perlemakan Hati Non-Alkoholik by Vanny Syafitri, Arnelis ., Efrida .

“…<p>Abstrak<br />Penyakit perlemakan hati non-alkoholik (non-alcoholic fatty liver disease) merupakan kondisi klinis yang sering ditemukan dalam bidang hepatologi. …”
Get full text

Liver Cell Death: Update on Apoptosis by Marc Bilodeau

“…Hepatocyte cell death is a cardinal feature of almost every liver disease. Apoptosis is a mode of cell death characterized by specific morphological and biochemical features. …”
Get full text

Role of NKT Cells in the Pathogenesis of NAFLD by Kazuto Tajiri, Yukihiro Shimizu

“…Nonalcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease and shows various inflammatory changes in the liver. …”
Get full text

Co-infection with hepatitis B and human immunodeficiency virus: epidemiology, pathogenesis, and treatment by Yaozu He, Weiyin Lin, Fei Gu, Xianglong Lan, Linghua Li, Haijuan Wang

“…Thus, the screening and follow-up of co-infected patients are vital formonitoring of liver disease progression. This study reviews the natural history and pathogenesis of liver disease in the context of HBV/HIV co-infection, current treatments for HBV in patients with HIV, and treatment outcomes in coinfected individuals.…”
Get full text

Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis by Paul Roderick, Peter Clive Hayes, Julie Parkes, Ryan Buchanan, Oliver John Kennedy, Jonathan Andrew Fallowfield

“…Objectives To examine the association between coffee, including caffeinated and decaffeinated coffee, with hepatocellular carcinoma (HCC) and assess the influence of HCC aetiology and pre-existing liver disease.Design We performed a systematic review and meta-analysis. …”
Get full text

Impact of hepatic steatosis on the efficacy of antiviral treatment for chronic hepatitis B and the establishment of predictive model: a cohort study by Guanghui Ren, Kaining Jia, Shi Yin, Yunpeng Guan, Qingwei Cong, Ying Zhu

Get full text

Case of acute drug-induced hepatitis after halothane anesthesia by I. Yu. Pirogova, Ye. V. Berestova, O. Yu. Bastrikov, Ye. B. Kovaleva, T. P. Petukhova, M. V. Guseva, I. A. Gubina, I. V. Rezepin, S. P. Sinitsyn

“…The most important factors determining favorable prognosis at drug-induced liver disease, include adequate doses of glucocorticosteroids, application of MARS-therapy and absence of background liver disease. …”
Get full text

Real-world effectiveness of sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir against genotype 3 hepatitis C virus infection: a systematic r... by Liwei Zhuang, Liwei Zhuang, Junnan Li, Yu Zhang, Shibo Ji, Huichun Xing, Huichun Xing

“…IntroductionDirect antiviral agents (DAAs) have dramatically changed the landscape of liver diseases associated with chronic hepatitis C virus (HCV) infection. …”
Get full text

Large annotated ultrasound dataset of non-alcoholic fatty liver from Saudi hospitals for analysis and applicationsOpen Science framework or (OSF) by Fahad Alshagathrh, Mahmood Alzubaidi, Khalid Alswat, Ali Aldhebaib, Bushra Alahmadi, Meteb Alkubeyyer, Abdulaziz Alosaimi, Amani Alsadoon, Maram Alkhamash, Jens Schneider, Mowafa Househ

“…This study presents a comprehensive ultrasound image dataset for Non-Alcoholic Fatty Liver Disease (NAFLD), addressing the critical need for standardized resources in AI-assisted diagnosis. …”
Get full text

HIV Infection and TLR Signalling in the Liver by Megan Crane, Kumar Visvanathan, Sharon R. Lewin

“…Despite the availability of effective combination antiretroviral therapy (cART), liver disease is one of the leading causes of morbidity and mortality in Human Immunodeficiency Virus (HIV)-infected individuals, specifically, in the presence of viral hepatitis coinfection. …”
Get full text

Hepatocellular Carcinoma in a 24-Year-Old Female with Beckwith–Wiedemann Syndrome: A Case Report and Review of the Literature by Carolyn G. Ahlers, Quoc-Huy Trinh, Martin Montenovo

“…Although HCC typically occurs in elderly adults or those with underlying liver disease, in this case, we show that HCC can occur in a young adult with BWS without any underlying liver disease.…”
Get full text

Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis by D. V. Garbuzenko

“…In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver fibrosis-specific drug therapy and treatment for metabolic syndrome-related diseases. …”
Get full text